Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-20-001995
Filing Date
2020-07-16
Accepted
2020-07-16 17:11:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g07422unu_07162020.htm SC 13G 283968
2 JOINT FILING AGREEMENT ex991to13g07422unu_07162020.htm EX-99.1 10554
  Complete submission text file 0000921895-20-001995.txt   296222
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Subject) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90431 | Film No.: 201032045
SIC: 2834 Pharmaceutical Preparations